Why the study?
The paper aims to examine the features of the combined course of acute coronary syndrome and diabetes mellitus, including epidemiology, pathogenesis, prognosis, and treatment principles.
How does diabetes mellitus affect the prognosis of acute coronary syndrome, and what are the principles of glucose-lowering therapy in these patients?
How does diabetes mellitus affect the prognosis of acute coronary syndrome, and what are the principles of glucose-lowering therapy in these patients?
This review highlights that patients with ACS and type 2 diabetes can generally continue their baseline glucose-lowering therapies, avoiding thiazolidinediones and biguanides, without a mandatory switch to insulin.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Kokozheva et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: